insights_auto
Why is KLRS down 5.26%?
Dive Deeperchevron_right
KLRS:NASDAQ
Kalaris Therapeutics Inc
$2.70
arrow_downward
-5.26%(-0.15) 1D
$2.70
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 2, 4:00:01āÆPM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KLRS...
Open
$2.90
High
$2.90
Low
$2.51
Mkt. cap
64.27M
Avg. vol.
64.48K
Volume
235.90K
52-wk high
$11.88
52-wk low
$2.51
EPS
-$2.09
Beta
0.42
Shares outstanding
23.80M
No. of employees
20
Open
$2.90
High
$2.90
Low
$2.51
Mkt. cap
64.27M
Avg. vol.
64.48K
Volume
235.90K
52-wk high
$11.88
52-wk low
$2.51
EPS
-$2.09
Beta
0.42
Shares outstanding
23.80M
No. of employees
20
News stories
From web sources and news partners
PR Newswire
·
1 hour ago
Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the Week
RealClearMarkets
·
4 hours ago
Here Are the Corporations Joining S&P 500
BigGo Finance
·
14 hours ago
Dow extends gains, rises 250 points to 51,176 as jobs report cools rate-hike bets
U.S. Global Investors
·
15 hours ago
Gold Stumbled in September, but Gold Miners Beat Every Sector in the S&P 500
About Kalaris Therapeutics Inc
CEO-
Employees20
Founded2019
HeadquartersBerkeley Heights, New Jersey, United States
SectorBiotechnology
Websitekalaristx.com